Regulation of interleukin 3 receptor α chain (IL-3Rα) on human monocytes by interleukin (IL)-4, IL-10, IL-13, and transforming growth factor β (TGF-β)

被引:12
作者
Leveque, C [1 ]
Grafte, S [1 ]
Paysant, J [1 ]
Soutif, A [1 ]
Lenormand, B [1 ]
Vasse, M [1 ]
Soria, C [1 ]
Vannier, JP [1 ]
机构
[1] Fac Med & Pharm Rouen, Lab DIFEMA, F-76803 St Etienne, France
关键词
IL-3 receptor alpha chain; IL-4; monocytes;
D O I
10.1006/cyto.1997.0324
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human interleukin 3 receptor (IL-3R) is constitutively expressed on committed haematopoietic stem cells, where it mediates proliferation and differentiation. This receptor is also expressed by monocytes and may induce functional activation. Interleukin (IL)-4, IL-10, IL-13, and transforming growth factor beta (TGF-beta) have different effects on human monocytes, As IL-3R may be regulated by different cytokines, whether the above-mentioned cytokines were able to modulate the alpha chain of IL-3R (IL-3R alpha) on monocytes was examined. Effects on IL-3R alpha antigen (Ag) expression were analysed by direct immunofluorescence and flow cytometry, Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect variations in IL-3R alpha mRNA expression. IL-10 and TGF-beta were found to downregulate IL-3R alpha Ag, In contrast, IL-4 and IL-13 both caused a dose- and time-dependent increase. A maximum effect was observed at 1 ng/ml of IL-4 for 18 h, Furthermore, in RT-PCR, IL-4 was found to slightly up-regulate IL-3R alpha mRNA expression. These observations suggest that IL-4 and IL-13 play a role in the regulation of IL-3R alpha expression and the effects of cytokines on human monocytes may be mediated, in part, through the regulation of IL-3R, (C) 1998 Academic Press.
引用
收藏
页码:487 / 494
页数:8
相关论文
共 40 条
[1]  
BUDEL LM, 1990, BLOOD, V75, P1439
[2]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[3]   INTERLEUKIN-3 PROTECTS MURINE BONE-MARROW CELLS FROM APOPTOSIS INDUCED BY DNA DAMAGING AGENTS [J].
COLLINS, MKL ;
MARVEL, J ;
MALDE, P ;
LOPEZRIVAS, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1043-1051
[4]   STIMULATORY AND INHIBITORY EFFECTS OF INTERLEUKIN (IL)-4 AND IL-13 ON THE PRODUCTION OF CYTOKINES BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRIMING FOR IL-12 AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION [J].
DANDREA, A ;
MA, XJ ;
ASTEAMEZAGA, M ;
PAGANIN, C ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :537-546
[5]  
ELLIOTT MJ, 1991, BLOOD, V77, P2739
[6]  
ELLIOTT MJ, 1990, J IMMUNOL, V145, P167
[7]  
ELLIOTT MJ, 1989, BLOOD, V74, P2349
[8]   INHIBITION OF CYTOKINE PRODUCTION BY CYCLOSPORINE-A AND TRANSFORMING GROWTH-FACTOR-BETA [J].
ESPEVIK, T ;
FIGARI, IS ;
SHALABY, MR ;
LACKIDES, GA ;
LEWIS, GD ;
SHEPARD, HM ;
PALLADINO, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (02) :571-576
[9]   HUMAN RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-3 CAUSE BASOPHIL HISTAMINE-RELEASE [J].
HAAKFRENDSCHO, M ;
ARAI, N ;
ARAI, K ;
BAEZA, ML ;
FINN, A ;
KAPLAN, AP .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (01) :17-20
[10]  
HALLEK M, 1992, BLOOD, V80, P1736